Skip to main content
. 2020 Dec 22;86(3):297–304. doi: 10.1097/QAI.0000000000002592

TABLE 2.

Clinical Characteristics of Adults Receiving HIV Care in the United States, 2014–2019, the Medical Monitoring Project

Risk Factor for Severe COVID-19 Sample Size Weighted Col % (95% CI)
Total 11,562
Comorbidities in the past 24 months*
 Obesity 1476 12.3 (11.4 to 13.1)
 Chronic kidney disease 1390 11.7 (10.8 to 12.6)
 Diabetes 1503 12.6 (11.9 to 13.4)
 Chronic obstructive pulmonary disease 1168 10.1 (9.4 to 10.8)
 Immunocompromised from organ transplantation 21 0.1 (0.1 to 0.2)
 Heart disease 1114 9.3 (8.7 to 10.0)
 Sickle cell disease 11 0.1 (0.0 to 0.1)
Any comorbidity in the past 24 months* 4473 37.9 (36.6 to 39.2)
Age
 ≥50 yrs 6129 51.6 (50.4 to 52.8)
 ≥65 yrs 993 8.3 (7.5 to 9.0)
HIV control during the past 24 mo
 Lowest CD4 count <200 cells/µL 1539 13.2 (12.2 to 14.2)
 Any HIV RNA ≥200 copies/mL 3070 27.6 (26.1 to 29.2)
 Any AIDS-defining illness 727 5.9 (5.5 to 6.4)
 Poorly controlled HIV (any CD4 count <200 cells/µL, any HIV RNA ≥200 copies/mL, or any AIDS-defining illness) 3990 35.8 (34.4 to 37.2)
Combinations of any comorbidity, age, and poorly controlled HIV
 Any comorbidity or age ≥50 yrs 7614 64.5 (63.3 to 65.7)
 Any comorbidity or age ≥65 yrs 4868 41.2 (40.0 to 42.4)
 Any comorbidity or poorly controlled HIV 6898 61.3 (59.9 to 62.7)
 Any comorbidity, age ≥50 years, or poorly controlled HIV 9125 79.7 (78.7 to 80.7)
 Any comorbidity, age ≥65 years, or poorly controlled HIV 7203 63.9 (62.7 to 65.1)
*

Defined as documented diagnosis in the medical record at the usual place of HIV care.

Estimate is unstable. Coefficient of variation is ≥ 0.3.

AIDS-defining opportunistic illness defined by CDC during the past 24 months: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5710a1.htm

CD4, CD4+ T-lymphocyte cell.